Viewing Study NCT00081159


Ignite Creation Date: 2025-12-24 @ 3:04 PM
Ignite Modification Date: 2026-03-29 @ 11:53 PM
Study NCT ID: NCT00081159
Status: COMPLETED
Last Update Posted: 2016-11-10
First Post: 2004-04-07
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Cancer View
None Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent prostate cancer View
None stage IV prostate cancer View
None bone metastases View